AppMed Inc. is a Québec-based digital health company that helps better manage narrow range therapies. Its online platform, AppMed®, recognized by Health Canada, combines pharmakinetic modeling, patient data collection and adherence monitoring. The goal is to allow for safer personalized dosing, improve the effectiveness of treatments, and reduce side effects.

OUR OFFERING

  • AppMed Assists Healthcare Professionals and Researchers
  • Precisely Determine Drug Dosage
  • Remotely Evaluate Clinical Response
  • Observe Adherence

OUR PLATFORM

  • Web-Based and Highly Secure
  • SaMD (Software as a Medical Device) Classe 2 Approved by Health Care Canada
  • Scalable as AppMed Encompasses Various Therapeutic Areas
  • Responsive as AppMed Adapts to Desktops and Mobile Devices

OUR SOLUTIONS

  • 3 independent “À la Carte” Interconnected Solutions
  • Dosage Optimisation: Model-Informed Precision Dosing Using Pharmacokinetic Modelling
  • Dosage Monitoring: Remote Therapeutic Drug Monitoring Using Digital Medical Questionnaires and Connected Devices (Scales, Blood Pressure Monitors)
  • Dosage Adherence: Remote Medication Dispensing Systems

MICROSAMPLING

  • Remote microsampling.
  • Patients may take painless blood sampling from home or work.
  • HCPs may send remote microsampling tasks to their patients via our Platform.

Latest News

Commitment to innovation

July 2024, the French Company Thess Corporate and the Canadian Company AppMed have entered into a reciprocal marketing agreement for their respective technological innovations in North America and Europe.

Contact Us

2025 Rue Michelin, Laval, Québec

H7L 5B7, Canada

info@appmed.ca

Telephone: 1-888-277-3660